Terms: = Cervical cancer AND uPA
51 results:
1. Clinicopathological features and immunophenotype of Silva pattern system in endocervical adenocarcinoma.
Zeng C; Wu JK; Lu X
Int J Exp Pathol; 2023 Jun; 104(3):140-150. PubMed ID: 36928883
[TBL] [Abstract] [Full Text] [Related]
2. Epidermal growth factor receptor regulates fibrinolytic pathway elements in cervical cancer: functional and prognostic implications.
Gomes FG; Almeida VH; Martins-Cardoso K; Martins-Dinis MMDC; Rondon AMR; Melo AC; Tilli TM; Monteiro RQ
Braz J Med Biol Res; 2021; 54(6):e10754. PubMed ID: 33886813
[TBL] [Abstract] [Full Text] [Related]
3. Ganoderma lucidum: A rational pharmacological approach to surmount cancer.
Ahmad MF
J Ethnopharmacol; 2020 Oct; 260():113047. PubMed ID: 32504783
[TBL] [Abstract] [Full Text] [Related]
4. [Gelatinases A and B and their endogenous regulators in the corpus uteri in squamous cell cervical carcinoma].
Timoshenko OS; Gureeva TA; Kugaevskaya EV; Zavalishina LE; Andreeva YY; Solovyeva NI
Arkh Patol; 2018; 80(6):22-28. PubMed ID: 30585589
[TBL] [Abstract] [Full Text] [Related]
5.
Liao CL; Chu YL; Lin HY; Chen CY; Hsu MJ; Liu KC; Lai KC; Huang AC; Chung JG
Anticancer Res; 2018 Jul; 38(7):3989-3997. PubMed ID: 29970522
[TBL] [Abstract] [Full Text] [Related]
6. Urokinase-plasminogen activator protects periodontal ligament fibroblast from oxidative induced-apoptosis and DNA damage.
Ahmad Akhoundi MS; Rokn A; Bagheri R; Momeni N; Hodjat M
J Periodontal Res; 2018 Oct; 53(5):861-869. PubMed ID: 29920670
[TBL] [Abstract] [Full Text] [Related]
7. Effect of a synthetic inhibitor of urokinase plasminogen activator on the migration and invasion of human cervical cancer cells in vitro.
Wang X; Jiang Z; An J; Mao X; Lin F; Sun P
Mol Med Rep; 2018 Mar; 17(3):4273-4280. PubMed ID: 29328476
[TBL] [Abstract] [Full Text] [Related]
8. Downregulation of Extracellular Matrix Metalloproteinase Inducer by scFv-M6-1B9 Intrabody Suppresses cervical cancer Invasion Through Inhibition of Urokinase-Type Plasminogen Activator.
Panich T; Tragoolpua K; Pata S; Tayapiwatana C; Intasai N
Cancer Biother Radiopharm; 2017 Feb; 32(1):1-8. PubMed ID: 28118037
[TBL] [Abstract] [Full Text] [Related]
9. Kallistatin Suppresses Cell Proliferation and Invasion and Promotes Apoptosis in cervical cancer Through Blocking NF-κB Signaling.
Wang T; Shi F; Wang J; Liu Z; Su J
Oncol Res; 2017 May; 25(5):809-817. PubMed ID: 27983915
[TBL] [Abstract] [Full Text] [Related]
10. Knockdown of Pentraxin 3 suppresses tumorigenicity and metastasis of human cervical cancer cells.
Ying TH; Lee CH; Chiou HL; Yang SF; Lin CL; Hung CH; Tsai JP; Hsieh YH
Sci Rep; 2016 Jul; 6():29385. PubMed ID: 27377307
[TBL] [Abstract] [Full Text] [Related]
11. [Matrix metalloproteinases and their endogenous regulators in squamous cervical carcinoma (review of the own data)].
Solovуeva NI; Timoshenko OS; Gureeva TA; Kugaevskaya EV
Biomed Khim; 2015; 61(6):694-704. PubMed ID: 26716740
[TBL] [Abstract] [Full Text] [Related]
12. Decreased expression of the plasminogen activator inhibitor type 1 is involved in degradation of extracellular matrix surrounding cervical cancer stem cells.
Sato M; Kawana K; Adachi K; Fujimoto A; Yoshida M; Nakamura H; Nishida H; Inoue T; Taguchi A; Takahashi J; Kojima S; Yamashita A; Tomio K; Nagamatsu T; Wada-Hiraike O; Oda K; Osuga Y; Fujii T
Int J Oncol; 2016 Feb; 48(2):829-35. PubMed ID: 26676222
[TBL] [Abstract] [Full Text] [Related]
13. [Matrix metalloproteinases 2 and 9, their endogenous regulators, and angiotensin-converting enzyme in cervical squamous cell carcinoma].
Timoshenko OS; Kugaevskaya EV; Gureeva TA; Zavalishina LE; Andreeva YY; Solovуeva NI
Arkh Patol; 2015; 77(5):31-35. PubMed ID: 26978018
[TBL] [Abstract] [Full Text] [Related]
14. Downregulation of FoxM1 inhibits proliferation, invasion and angiogenesis of HeLa cells in vitro and in vivo.
Chen H; Zou Y; Yang H; Wang J; Pan H
Int J Oncol; 2014 Dec; 45(6):2355-64. PubMed ID: 25201015
[TBL] [Abstract] [Full Text] [Related]
15. [Matrix metalloproteinases (MMP)--MMP-1,-2,-9 and its endogenous activity regulators in transformed by E7 oncogene HPV16 and HPV18 cervical carcinoma cell lines].
Ryzhakova OS; Solov'eva NI
Biomed Khim; 2013; 59(5):530-40. PubMed ID: 24479343
[TBL] [Abstract] [Full Text] [Related]
16. Fisetin inhibits migration and invasion of human cervical cancer cells by down-regulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-κB signaling pathway.
Chou RH; Hsieh SC; Yu YL; Huang MH; Huang YC; Hsieh YH
PLoS One; 2013; 8(8):e71983. PubMed ID: 23940799
[TBL] [Abstract] [Full Text] [Related]
17. Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection.
Steinestel J; Cronauer MV; Müller J; Al Ghazal A; Skowronek P; Arndt A; Kraft K; Schrader M; Schrader AJ; Steinestel K
PLoS One; 2013; 8(5):e65189. PubMed ID: 23724131
[TBL] [Abstract] [Full Text] [Related]
18. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2012 Sep; 28(3):768-76. PubMed ID: 22736175
[TBL] [Abstract] [Full Text] [Related]
19. Genetic polymorphism of urokinase-type plasminogen activator is interacting with plasminogen activator inhibitor-1 to raise risk of cervical neoplasia.
Tee YT; Wang PH; Tsai HT; Lin LY; Lin HT; Yang SF; Hsieh YH; Ying TH
J Surg Oncol; 2012 Aug; 106(2):204-8. PubMed ID: 22354580
[TBL] [Abstract] [Full Text] [Related]
20. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway.
Au Yeung CL; Tsang TY; Yau PL; Kwok TT
Oncogene; 2011 May; 30(21):2401-10. PubMed ID: 21242962
[TBL] [Abstract] [Full Text] [Related]
[Next]
